Uto Keiichi, Sakamoto Seisuke, Que Weitao, Shimata Keita, Hashimoto Shintaro, Sakisaka Masataka, Narita Yasuko, Yoshii Daiki, Zhong Lin, Komohara Yoshihiro, Li Xiao-Kang, Inomata Yukihiro, Hibi Taizo
Department of Transplantation and Pediatric Surgery, Postgraduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, 860-8556, Japan.
Organ Transplant Center, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan.
BMC Gastroenterol. 2019 Feb 8;19(1):25. doi: 10.1186/s12876-019-0939-7.
Liver transplantation (LT) is considered the standard treatment for end-stage liver disease, but ideal donors remain in limited supply, resulting in an unavoidable increase in the need to use grafts from marginal donors. The attenuation of ischemia-reperfusion injury (IRI) in such marginal donors is therefore crucial for reducing the possibility of the primary non-function of grafts and graft loss. Some reports have found that molecular-hydrogen showed antioxidant and anti-inflammatory effects in preventing IRI in some non-hepatic transplant models. Therefore, we investigated whether or not molecular-hydrogen could attenuate IRI in LT model rats.
We used a hydrogen-rich water bath to dissolve hydrogen into solution and graft tissues and performed isogenic and orthotopic LT in Lewis rats with University of Wisconsin (UW) solution. Blood and tissue samples were collected 6 h after the reperfusion. Hepatic enzymes in serum were measured. Pathological findings including the expressions of cytokines and heme oxygenase (HO)-1 in liver tissues were evaluated.
The concentration of hydrogen inside the graft tissues increased depending on the storage time, plateauing after 1 h. Serum liver enzyme levels were significantly lower and the histology score of liver damage markedly attenuated in the group given grafts preserved in hydrogen-rich UW solution than in the control group. The hydrogen-rich UW solution group also showed less oxidative damage and hepatocyte apoptosis than the control group, and the expression of proinflammatory cytokines tended to be lower while the protein levels of HO-1 were significantly increased (n = 3-12 per group, P < 0.05).
Storage of liver grafts in hydrogen-rich UW solution resulted in superior functional and morphologic protection against IRI via the up-regulation of HO-1 expression.
肝移植(LT)被认为是终末期肝病的标准治疗方法,但理想供体仍然供应有限,这导致不可避免地增加了使用边缘供体移植物的需求。因此,减轻此类边缘供体的缺血再灌注损伤(IRI)对于降低移植物原发性无功能和移植物丢失的可能性至关重要。一些报告发现,分子氢在某些非肝移植模型中对预防IRI具有抗氧化和抗炎作用。因此,我们研究了分子氢是否可以减轻LT模型大鼠的IRI。
我们使用富氢水浴将氢溶解到溶液和移植组织中,并在Lewis大鼠中用威斯康星大学(UW)溶液进行同基因和原位肝移植。再灌注6小时后采集血液和组织样本。测量血清中的肝酶。评估包括肝组织中细胞因子和血红素加氧酶(HO)-1表达在内的病理结果。
移植组织内氢的浓度随保存时间增加而升高,1小时后达到稳定状态。与对照组相比,接受保存在富氢UW溶液中的移植物的组血清肝酶水平显著降低,肝损伤的组织学评分明显减轻。富氢UW溶液组也比对照组显示出更少的氧化损伤和肝细胞凋亡,促炎细胞因子的表达趋于降低,而HO-1的蛋白水平显著升高(每组n = 3 - 12只,P < 0.05)。
将肝移植物保存在富氢UW溶液中可通过上调HO-1表达对IRI产生优异的功能和形态学保护作用。